Acute Effects of a Heat-not-burn Tobacco Product on Pulmonary Function in

Status Completed

Clinical Trial Summary

IQOS ("I-Quit-Ordinary-Smoking,") is a type of "heat-not-burn" (HNB) tobacco product. There is evidence of a growing number of young people who try IQOS as a 'safe' alternative of cigarette. The effect of the acute exposure to IQOS smoke on pulmonary function of healthy non smokers has not been studied extensively.

Objectives: Evaluation of the acute effects of IQOS on pulmonary function,exhaled CO, O2 Saturation, arterial pressure and heart rate.

Methods: Healthy non smokers, underwent exhaled CO measurement, spirometry including flows, volumes and diffusion capacity, and measurement of their respiratory resistances at 5, 10 and 20 Hz (R5Hz, R10Hz and R20Hz) with the use of an impulse oscillometry system (IOS) before and after the use of an IQOS. Additionally heart rate and arterial blood pressure were also measured.

Clinical Trial Description

All participants underwent pulmonary function tests (PFT) (MasterScreen PFT, Jaeger, Wurzburg, Germany) and total respiratory resistances measurement with an impulse oscillometry system (IOS)( (Viasys Jaeger MasterScreen IOS system).From the basic pulmonary measurements (flows and dynamic lung volumes), Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC), Tiffenau index (FEV1/FVC, FEV1%), Peak Expiratory Flow (PEF), Maximal Expiratory Flow (MEF) at 25%, 50%, and 75% of vital capacity, Functional Residual Capacity (FRC), Total Lung Capacity (TLC), Residual Volume (RV), Diffusion Capacity (DLCO) were measured. Each manoeuvre was repeated for at least three technically acceptable forced expiratory flow curves in order to attain the best results. Respiratory impedance at 5 Hz (Z5Hz) and respiratory resistance at 5, 10, and 20 Hz (R5Hz, R10Hz, and R20Hz, respectively), reactance at 5, 10, and 20 Hz and resonant frequency were assessed with IOS. Heart rate, saturation of O2 (oxymetry) and arterial blood pressure were also measured. Exhaled CO measurement (piCO Smokerlyzer,Bedfont Scientific Ltd, Kent, U.K.) was performed After smoking heated tobacco (IQOS): 5 minutes after smoking IQOS , they repeated again PFTs, IOS, exhaled CO heart rate, saturation of O2 (oximetry) and arterial blood pressure measurements. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03995329
Study type	Interventional
Source	Aristotle University Of Thessaloniki
Contact
Status	Completed
Phase	N/A
Start date	June 19, 2019
Completion date	July 10, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01143493` - The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease
Completed	`NCT04824573` - Effects of Manual Therapy and Inspiratory Muscle Training	N/A
Recruiting	`NCT01881945` - Validation of Study in Respiratory Physiology and it Interactions	N/A
Completed	`NCT03098784` - Nanoparticles Emitted by Aircraft Engines, Impact on Respiratory Function	N/A
Not yet recruiting	`NCT04391361` - The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS	Phase 2
Completed	`NCT06121960` - Evaluation of Respiratory Function During Self-induced Cognitive Trance	N/A
Completed	`NCT03815799` - The Effect of Ultrasound-Guided Erector Spinae Block on Respiratory Function After Laparoscopic Cholecystectomy	N/A
Active, not recruiting	`NCT01287000` - Gulf Long-Term Follow-Up Study
Active, not recruiting	`NCT04519255` - Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT
Not yet recruiting	`NCT05662072` - Motor Imagery and Action Observation in Respiratory Training	N/A
Completed	`NCT03889990` - Acute Effects of a Heat-not-burn Tobacco Product on Pulmonary Function	N/A
Completed	`NCT02074397` - Distant Extrafascial Injection vs Subfascial Injection for Interscalene Block: Acute Pain Outcomes and Rates of Complications	N/A
Suspended	`NCT06198946` - External Diaphragm Pacing Therapy and Correlation Analysis of Trunk Balance and Respiratory Function in Stroke Patients	N/A
Completed	`NCT03985917` - Singing Groups for Seniors: Well-Being, Cognitive Function and Health	N/A
Not yet recruiting	`NCT02491762` - The Effect of Breast Reconstruction Surgery Using Tissue Expanders on Respiratory Functions	N/A
Recruiting	`NCT06041126` - The Effect of Clinical Parameters on Muscle Oxygenation in Patients With COPD
Completed	`NCT01748643` - CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity	Phase 4
Completed	`NCT06175286` - Effect of a Respiratory Training Program on Woodwind and Brass Players	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Acute Effects of a Heat-not-burn Tobacco Product on Pulmonary Function in Healthy Non Smokers.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms